Bill 118 s 2129, also known as the Ensuring Access to Lower-Cost Medicines for Seniors Act, aims to address the issue of high prescription drug costs for senior citizens in the United States. The bill was introduced in the Senate and is currently under consideration.
The main goal of the bill is to increase access to lower-cost prescription medications for seniors by allowing the importation of safe and affordable drugs from Canada. This would help to lower the financial burden on older Americans who often struggle to afford the medications they need to manage their health conditions.
The bill includes provisions to ensure that the imported drugs meet the same safety and quality standards as medications sold in the US. It also requires the Secretary of Health and Human Services to certify that the importation of drugs from Canada will result in cost savings for consumers.
Additionally, the bill includes measures to increase transparency in drug pricing and to promote competition in the pharmaceutical industry. This includes requiring drug manufacturers to provide more information about the costs of producing their medications and to justify price increases.
Overall, the Ensuring Access to Lower-Cost Medicines for Seniors Act aims to make prescription drugs more affordable for senior citizens in the US by allowing the importation of safe and affordable medications from Canada, increasing transparency in drug pricing, and promoting competition in the pharmaceutical industry.